| Product Code: ETC8561675 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The hemostatic agents import market in New Zealand experienced steady growth in 2024, with key exporting countries including China, USA, Germany, Finland, and the UK. The market showed low concentration levels with a Herfindahl-Hirschman Index (HHI) indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was impressive at 10.5%, and the growth rate from 2023 to 2024 surged to 18.52%, signaling a strong momentum in the industry. New Zealand`s reliance on these top exporting countries showcases a global supply chain supporting the country`s healthcare needs.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Hemostatic Agents Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Hemostatic Agents Market - Industry Life Cycle |
3.4 New Zealand Hemostatic Agents Market - Porter's Five Forces |
3.5 New Zealand Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 New Zealand Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 New Zealand Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgeries and procedures in New Zealand |
4.2.2 Growing awareness and adoption of advanced medical technologies |
4.2.3 Rising prevalence of chronic diseases leading to higher demand for hemostatic agents |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of hemostatic agents |
4.3.2 High cost associated with advanced hemostatic products |
4.3.3 Limited availability of skilled healthcare professionals to administer hemostatic agents |
5 New Zealand Hemostatic Agents Market Trends |
6 New Zealand Hemostatic Agents Market, By Types |
6.1 New Zealand Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 New Zealand Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 New Zealand Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 New Zealand Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 New Zealand Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 New Zealand Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 New Zealand Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 New Zealand Hemostatic Agents Market Import-Export Trade Statistics |
7.1 New Zealand Hemostatic Agents Market Export to Major Countries |
7.2 New Zealand Hemostatic Agents Market Imports from Major Countries |
8 New Zealand Hemostatic Agents Market Key Performance Indicators |
8.1 Adoption rate of advanced hemostatic agents in surgical procedures |
8.2 Number of clinical trials and research studies conducted on hemostatic agents |
8.3 Rate of complications or adverse events associated with hemostatic agent usage in surgeries |
9 New Zealand Hemostatic Agents Market - Opportunity Assessment |
9.1 New Zealand Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 New Zealand Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 New Zealand Hemostatic Agents Market - Competitive Landscape |
10.1 New Zealand Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |